This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloid leukaemia
CD2_MYELOID_LEUKAEMIA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
922 |
4. Check minimum number of eventsNone |
922 |
5. Include endpointsNone |
922 |
6. Filter based on genotype QC (FinnGen only) |
922 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia myeloides
Similar endpoints
↥List of similar endpoints to
Myeloid leukaemia
based on the number of shared cases.
Similar with more cases:
- Myeloid leukaemia
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 922 | 405 | 517 |
| Unadjusted period prevalence (%) | 0.19 | 0.14 | 0.23 |
| Median age at first event (years) | 63.95 | 58.58 | 68.16 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 912
- Matched controls
- 9119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
567
*
XW000
NOMESCO Finland
Bone marrow biopsy
71.8
323.0
518
164
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
168.7
323.0
696
171
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
304
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
300.1
271
*
189
Kela drug reimbursment
Imatinib
388.1
190.0
185
6
WW500
NOMESCO Finland
Blood transfusion
23.6
179.5
266
156
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
31.8
168.6
227
94
L01XE01
ATC
[U] imatinib; oral
320.3
161.2
159
6
127
Kela drug reimbursment
Transplant complication
47.3
134.3
164
42
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
133.7
125
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
165.1
123.8
128
9
M04AA01
ATC
allopurinol; systemic
6.7
118.8
362
810
L01XX05
ATC
hydroxycarbamide; oral
49.5
114.9
139
33
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
420.8
114.2
112
*
A05AA02
ATC
ursodeoxycholic acid; oral
35.7
111.6
145
48
L03AA02
ATC
filgrastim; parenteral
19.7
110.6
172
106
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
343.2
92.7
92
*
R50.9
ICD-10 Finland
Fever, unspecified
5.7
90.6
306
737
A04AA01
ATC
ondansetron; systemic, rectal
8.8
88.6
206
293
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
85.4
297
733
316
Kela drug reimbursment
Imatinib
300.7
82.0
82
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.7
79.5
263
605
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
46.0
77.5
95
23
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.9
75.2
185
283
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
123.4
74.2
79
7
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
204.0
73.3
75
*
J05AB11
ATC
valaciclovir; oral
5.2
71.7
256
634
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.7
69.7
174
270
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.5
68.3
127
116
L01BB02
ATC
mercaptopurine; oral
50.8
65.8
79
17
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
66.9
64.5
74
12
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.6
64.4
148
200
152
Kela drug reimbursment
Nilotinib
+∞
64.3
61
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
60.1
57
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
616.4
59.4
58
*
J01MA12
ATC
levofloxacin; systemic
3.8
57.4
306
1081
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
20.9
56.0
84
44
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
43.8
55.9
69
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
55.0
122
154
D70.89
ICD-10 Finland
Neutropenic splenomegaly
28.2
53.4
73
28
D64.9
ICD-10 Finland
Anaemia, unspecified
4.6
52.7
207
548
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
537.2
52.0
51
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
537.2
52.0
51
*
150
Kela drug reimbursment
Dasatinib
+∞
51.5
49
*
J02AC03
ATC
voriconazole; systemic
62.9
51.0
59
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
50.5
530
2962
WW200
NOMESCO Finland
Immunization
10.8
50.3
100
103
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
19.0
49.8
77
44
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
49.4
47
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.0
48.8
74
40
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.3
48.6
76
45
L01XX28
ATC
[D] imatinib; oral
+∞
48.4
46
*
L04AD01
ATC
ciclosporin; systemic
13.3
48.1
86
71
L01XE06
ATC
[U] dasatinib; systemic
+∞
46.2
44
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
129.3
46.2
49
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
23.2
45.1
65
30
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.2
44.2
79
65
L01XE08
ATC
[U] nilotinib; oral
+∞
43.1
41
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.6
41.1
111
187
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
29.2
40.8
55
20
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
40.5
123
241
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
39.6
230
834
ZX120
NOMESCO Finland
Intravenous
4.0
39.3
176
516
J01MA14
ATC
moxifloxacin; systemic
4.4
37.6
150
394
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
43.0
36.5
45
11
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
35.7
34
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
34.6
33
*
212
Kela drug reimbursment
Gout
8.1
34.0
79
106
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
33.5
317
1548
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
33.5
32
*
328
Kela drug reimbursment
Nilotinib
+∞
33.5
32
*
B73
ICPC
Leukaemia
93.6
33.0
36
*
J02AC04
ATC
posaconazole; systemic
+∞
32.5
31
*
L01EA03
ATC
nilotinib; oral
+∞
32.5
31
*
L04AA06
ATC
mycophenolic acid; systemic
11.4
32.2
61
57
ZX112
NOMESCO Finland
Subcutaneous
8.6
31.1
69
86
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.8
30.6
91
172
TGC00
NOMESCO Finland
Bronchial lavation
7.8
30.5
72
99
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
39.6
30.5
38
10
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
33.0
29.3
38
12
L04AA01
ATC
[U] ciclosporin; systemic
11.0
29.1
56
54
N02AA05
ATC
oxycodone; systemic
2.9
28.4
204
835
324
Kela drug reimbursment
Dasatinib
+∞
28.3
27
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.4
27.9
87
174
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.8
27.7
72
114
1DB06
NOMESCO Finland
NA
+∞
27.2
26
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
64.1
27.1
31
5
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.6
26.9
71
115
WW409
NOMESCO Finland
Other aferesis
99.8
26.8
29
*
Z51.5
ICD-10 Finland
Palliative care
4.1
26.7
109
289
J05AB01
ATC
aciclovir; systemic
2.5
26.2
244
1153
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
26.2
25
*
H02AB09
ATC
hydrocortisone; systemic
7.9
25.5
59
79
J02AC01
ATC
fluconazole; systemic
2.2
25.5
360
2089
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
25.1
129
415
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
40.1
25.0
31
8
C90.0
ICD-10 Finland
Multiple myeloma
11.8
24.9
46
41
H02AB04
ATC
methylprednisolone; systemic
2.8
24.9
182
748
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.3
24.4
77
156
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
24.2
250
1242
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
26.3
24.1
33
13
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
235.6
22.7
23
*
2AX04
NOMESCO Finland
NA
123.1
22.7
24
*
JN4BD
NOMESCO Finland
Extensive body CT
2.9
22.2
153
601
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
22.0
21
*
1BC07
NOMESCO Finland
NA
+∞
22.0
21
*
L01EA02
ATC
dasatinib; oral
+∞
22.0
21
*
TPH00
NOMESCO Finland
Phlebotomy
27.2
21.4
29
11
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
21.1
334
1990
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
20.9
20
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
27.8
20.1
27
10
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
75.2
19.8
22
*
L03AB05
ATC
interferon alfa-2b; parenteral
25.2
19.6
27
11
A40.8
ICD-10 Finland
Other streptococcal sepsis
15.2
19.0
31
21
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
18.8
18
*
H02AB06
ATC
prednisolone; systemic
1.9
18.4
445
3071
A41.8
ICD-10 Finland
Other specified sepsis
7.6
18.4
43
59
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
45.0
18.3
22
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
18.1
135
554
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
53.6
18.0
21
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.8
17
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
17.8
17
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
17.6
196
988
TAB00
NOMESCO Finland
Lumbar puncture
4.3
17.6
66
161
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.8
17.5
35
37
306
Kela drug reimbursment
Erythropoietin and darbepoetin
24.6
17.4
24
10
ZX121
NOMESCO Finland
Central venous catheter
26.2
17.0
23
9
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
26.2
17.0
23
9
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
16.7
16
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
+∞
16.7
16
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
91.8
16.6
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
13.9
16.1
27
20
A07AA02
ATC
nystatin; oral
3.1
16.0
91
314
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.0
15.9
51
106
5BA08
NOMESCO Finland
NA
17.6
15.7
24
14
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
15.7
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.7
15
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
86.6
15.6
17
*
B03XA01
ATC
erythropoietin; parenteral
11.5
15.3
28
25
ZX108
NOMESCO Finland
Inhalation
11.5
15.3
28
25
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
15.1
218
1221
B03XA02
ATC
darbepoetin alfa; parenteral
5.9
15.1
42
74
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.1
15.0
31
35
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
14.6
14
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
27.7
14.3
19
7
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
27.7
14.3
19
7
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
8.2
14.1
31
39
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.7
14.0
40
73
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
13.9
93
357
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
13.8
118
520
SPAT1088
SPAT
Blood transfusion
20.4
13.8
20
10
C03CA01
ATC
furosemide; systemic
1.8
13.7
316
2082
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.3
13.6
32
45
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
13.6
13
*
1DB07
NOMESCO Finland
NA
+∞
13.6
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.9
13.4
37
65
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
13.3
203
1159
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
13.1
56
155
JN4AD
NOMESCO Finland
Body CT examination
2.6
12.8
96
391
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
9.9
12.8
25
26
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
12.5
12
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
12.5
12
*
D45
ICD-10 Finland
Polycythaemia vera
8.8
12.1
25
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
11.9
347
2432
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.8
11.8
29
44
B02.9
ICD-10 Finland
Zoster without complication
3.0
11.7
67
232
F43.29
ICD-10 Finland
Adaptation disorder UNS
8.3
11.6
25
31
L03AA13
ATC
pegfilgrastim; parenteral
3.7
11.5
49
136
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
11.5
11
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.1
11.4
62
209
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
35.5
11.3
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
11.2
109
513
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
20.3
11.2
16
8
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.0
11.1
44
115
A98
ICPC
Health maint/preventive medicine
0.6
11.1
675
7611
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
43.9
10.9
13
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
43.9
10.9
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
12.1
10.9
19
16
D75.2
ICD-10 Finland
Essential thrombocytosis
10.7
10.8
20
19
JN6AD
NOMESCO Finland
CT of torso and neck
8.1
10.6
23
29
RS220
NOMESCO Finland
NA
7.1
10.6
25
36
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
10.3
95
432
L03AA04
ATC
NA
32.9
10.3
13
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
19.0
10.3
15
8
6BA02
NOMESCO Finland
NA
23.7
10.3
14
6
A02BC02
ATC
pantoprazole; systemic
1.6
10.2
561
4574
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
10.2
87
384
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
10.0
93
428
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
10.0
44
127
J01FF01
ATC
clindamycin; systemic
1.7
9.9
234
1528
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
26.3
9.8
13
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
26.3
9.8
13
5
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.8
171
1013
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
9.8
61
225
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
55.6
9.7
11
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
9.7
51
169
D64.8
ICD-10 Finland
Other specified anaemias
4.9
9.5
30
63
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
101.0
9.4
10
*
B74
ICPC
Malignant neoplasm blood other
101.0
9.4
10
*
A02BC01
ATC
omeprazole; systemic
1.7
9.4
255
1728
J01MA02
ATC
ciprofloxacin; systemic
1.6
9.4
349
2569
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
9.4
9
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
9.4
9
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
2AX05
NOMESCO Finland
NA
+∞
9.4
9
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.3
9.3
84
380
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.4
9.2
77
334
A01AB04
ATC
amphotericin B; local oral
2.7
9.1
63
248
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.6
255
1761
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
8.6
277
1958
E89.4
ICD-10 Finland
Postprocedural ovarian failure
90.9
8.4
9
*
L03AA10
ATC
lenograstim; parenteral
+∞
8.3
8
*
C92
ICD-10 Finland
Myeloid leukaemia
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
10.9
8.3
15
14
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.2
8.2
41
132
L01AA01
ATC
cyclophosphamide; systemic
17.3
8.1
12
7
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
22.2
8.0
11
5
H26.3
ICD-10 Finland
Drug-induced cataract
10.9
7.8
14
13
ED1AA
NOMESCO Finland
Mandipular X-ray examination
9.5
7.8
15
16
H02AB02
ATC
dexamethasone; systemic
2.0
7.8
96
502
RS221
NOMESCO Finland
NA
5.3
7.7
22
42
R4110
NOMESCO Finland
Physiotherapy
1.6
7.6
228
1575
K12.10
ICD-10 Finland
Stomatitis NOS
18.5
7.6
11
6
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
25.2
7.6
10
*
B37.7
ICD-10 Finland
Candidal sepsis
25.2
7.6
10
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.2
7.6
19
31
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.6
404
3186
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.9
7.5
29
76
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.1
7.4
22
44
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
7.4
37
119
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.5
7.4
18
28
B59
ICD-10 Finland
Pneumocystosis
80.7
7.4
8
*
1BC01
NOMESCO Finland
NA
80.7
7.4
8
*
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
7.4
7.2
16
22
M87.3
ICD-10 Finland
Other secondary osteonecrosis
30.3
7.2
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8.0
7.1
15
19
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
7.6
6.9
15
20
1CX01
NOMESCO Finland
NA
13.9
6.9
11
8
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.9
6.9
21
44
SPAT1074
SPAT
Venesection
9.4
6.8
13
14
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.2
6.8
33
105
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.8
154
984
C91.7
ICD-10 Finland
Other lymphoid leukaemia
40.4
6.8
8
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.7
6.7
27
74
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
6.7
97
537
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
6.6
58
261
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
8.8
6.6
13
15
A07AA09
ATC
vancomycin; oral
4.5
6.5
21
47
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
6.5
84
445
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
70.3
6.4
7
*
V03AC03
ATC
deferasirox; oral
70.3
6.4
7
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.6
6.3
15
23
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
6.3
6
*
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
6.3
6
*
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
2AA01
NOMESCO Finland
NA
+∞
6.3
6
*
J05AX18
ATC
letermovir; oral
+∞
6.3
6
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
6.3
6
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.2
88
483
B02AA02
ATC
tranexamic acid; systemic
1.8
6.2
109
643
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
8.7
6.1
12
14
WW300
NOMESCO Finland
Transfer of autologic stem cells
10.1
6.0
11
11
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.0
176
1203
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
538
876
13.35
307.65
18.6
4.0
299.9
252.0
u/l
2.08
528
821
304
132
33.87
307.65
5.0
1.5
—
—
—
0
0
197
126
19.61
236.33
1.5
1.4
109.6
104.7
u/ml
0.24
55
24
201
142
17.82
228.91
1.4
1.3
—
—
—
0
0
446
934
8.31
227.34
7.6
2.6
1.8
1.8
%
0.24
429
841
199
144
17.35
223.56
11.6
6.6
370.7
512.7
iu/ml
0.25
39
19
181
119
18.68
213.49
4.1
3.8
538.1
2409.3
u/ml
0.52
15
12
216
200
13.80
209.52
4.3
2.9
3.7
3.7
g/l
0.11
209
190
183
134
16.79
203.66
1.4
1.3
253.2
248.3
u/ml
0.05
116
76
312
523
8.51
191.89
3.1
2.9
9.5
10.9
g/l
4.86
299
480
189
187
12.46
174.37
4.1
1.7
—
—
—
0
0
191
192
12.29
174.35
3.8
1.6
—
—
—
0
0
409
1012
6.47
169.31
13.5
5.9
1.0
1.0
mmol/l
0.23
404
922
161
6
324.49
163.33
1.1
1.0
—
—
—
0
0
289
549
7.21
155.60
11.7
4.0
1.0
0.4
%
4.63
139
136
154
139
13.10
150.14
4.2
1.7
—
—
—
0
0
84
17
54.26
146.64
1.3
1.1
—
—
—
0
0
419
1207
5.53
142.51
11.4
3.5
0.8
0.8
mmol/l
0.26
406
1126
138
115
13.94
141.14
10.3
3.8
1.3
1.2
%
0.05
116
97
174
207
10.13
139.67
1.7
1.8
—
—
—
0
0
105
76
15.46
116.04
4.8
1.9
—
—
—
0
0
201
353
7.00
114.54
1.9
2.0
1.4
1.6
g/l
0.95
177
311
117
111
11.93
109.58
8.9
6.2
10.2
11.8
mg/l
2.48
112
102
105
84
13.98
109.46
4.9
1.8
—
—
—
0
0
491
1937
4.28
104.98
9.2
2.8
325.2
8054.8
umol/l
8.35
469
1663
86
52
18.14
104.17
1.8
1.3
—
—
—
0
0
65
19
36.73
103.42
1.7
1.4
—
—
—
0
0
92
0
+∞
97.67
15.3
0.0
—
—
—
0
0
79
47
18.29
96.33
5.6
1.9
413.2
713.4
e6/l
1.29
43
19
90
69
14.35
95.97
10.5
3.4
45.5
54.0
%
1.30
64
52
115
141
9.18
89.03
1.9
1.6
—
—
—
0
0
249
661
4.79
88.57
2.3
3.0
65.4
66.3
g/l
1.15
241
600
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
85
72
12.90
85.23
5.4
1.7
—
—
—
0
0
99
112
9.78
81.39
2.1
1.6
—
—
—
0
0
89
89
10.96
79.96
2.4
1.6
—
—
—
0
0
641
3436
3.84
79.86
24.5
6.0
31.6
27.1
%
12.96
624
3199
61
31
21.00
79.72
6.6
1.9
—
—
—
0
0
61
31
21.00
79.72
6.6
1.9
—
—
—
0
0
78
64
13.22
79.67
1.2
1.0
—
—
—
0
0
61
32
20.34
78.61
6.6
1.9
—
—
—
0
0
333
1192
3.81
77.59
5.0
2.1
29.1
29.8
s
1.59
324
1149
68
46
15.88
77.47
1.3
1.4
—
—
—
0
0
84
81
11.31
77.33
4.1
2.7
—
—
—
0
0
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
63
41
16.42
73.18
6.5
1.8
—
—
—
0
0
65
45
15.46
73.08
6.8
4.2
—
—
—
0
0
617
3385
3.49
70.59
21.9
5.7
49.8
57.8
%
30.95
599
3168
204
562
4.38
67.83
3.5
1.7
—
—
—
0
0
70
65
11.57
65.94
1.6
1.6
—
—
—
0
0
86
110
8.52
63.95
1.8
1.5
—
—
—
0
0
221
689
3.90
61.53
9.2
7.6
8.4
10.3
mmol/l
3.87
215
652
327
1317
3.30
61.11
4.4
1.8
—
—
—
0
0
43
19
23.69
59.26
8.7
1.9
—
—
—
0
0
92
144
6.99
57.23
1.3
1.2
151.9
32.2
u/l
2.89
82
128
670
4147
3.25
57.02
42.7
9.0
3.5
4.2
e9/l
2.73
630
3647
53
41
13.65
55.81
1.5
1.8
—
—
—
0
0
53
41
13.65
55.81
1.5
1.8
—
—
—
0
0
84
126
7.23
54.30
2.1
1.5
—
—
—
0
0
55
48
12.12
53.80
2.1
2.5
38.2
39.3
%
0.06
16
12
79
114
7.49
52.85
2.0
1.5
—
—
—
0
0
39
19
21.39
51.59
1.8
1.5
—
—
—
0
0
48
36
14.01
51.40
3.7
1.9
17.8
16.2
%
0.12
19
13
628
3878
2.94
51.08
26.1
6.4
11.5
11.6
umol/l
0.11
612
3677
75
108
7.47
50.23
5.0
1.6
34.0
32.4
pg
1.88
75
108
120
273
4.90
50.09
3.3
2.9
—
—
—
0
0
110
237
5.13
48.92
2.4
1.2
—
—
—
0
0
45
36
13.09
46.35
2.8
1.4
—
—
—
0
0
45
36
13.09
46.35
2.8
1.4
—
—
—
0
0
335
1557
2.81
46.34
3.2
1.7
3.2
1.2
mg/l
3.82
290
1211
31
11
29.13
45.98
1.3
4.0
—
—
—
0
0
49
47
10.95
44.96
2.6
1.4
—
—
—
0
0
93
189
5.36
44.09
1.6
2.1
26.7
12.3
mg/l
1.42
81
171
236
934
3.05
43.58
3.0
1.8
—
—
—
0
0
48
47
10.72
43.41
2.7
1.4
—
—
—
0
0
236
936
3.04
43.40
2.9
1.7
—
—
—
0
0
593
3742
2.64
42.91
20.4
7.1
1.2
1.2
mmol/l
0.87
513
3141
222
860
3.08
42.46
14.1
2.8
7.9
9.0
umol/l
0.36
214
760
28
10
28.85
41.36
1.4
1.7
—
—
—
0
0
124
341
4.05
40.30
2.9
1.9
6.4
2.3
ug/l
0.59
118
300
546
3425
2.46
38.23
17.4
6.2
1.2
1.2
mmol/l
1.43
521
3078
39
34
11.93
38.02
1.2
1.4
—
—
—
0
0
41
40
10.68
37.11
1.5
1.2
—
—
—
0
0
73
139
5.62
37.07
8.1
3.6
48.9
59.1
%
5.86
73
139
35
34
10.66
31.72
1.2
1.1
—
—
—
0
0
45
61
7.70
31.62
1.2
1.1
—
—
—
0
0
511
3284
2.25
31.48
15.2
4.9
33.9
35.1
g/l
4.98
498
3053
253
1209
2.51
31.20
2.4
2.5
15.5
12.7
umol/l
5.76
244
1124
337
1841
2.31
30.64
10.7
4.0
85.2
87.8
%
1.08
327
1797
228
1049
2.56
30.38
2.5
2.6
30.3
22.4
%
6.92
188
897
236
1113
2.51
29.78
2.4
2.5
2.2
2.3
g/l
4.67
225
1040
324
1768
2.28
29.28
12.3
2.4
—
—
—
0
0
511
3401
2.13
27.37
19.0
4.2
—
—
—
0
0
24
18
13.66
25.46
1.5
1.3
—
—
—
0
0
86
251
3.68
25.40
2.7
3.9
44.7
83.2
mg/l
0.80
74
204
85
247
3.69
25.27
2.2
3.9
42.6
1.9
ratio
—
5
22
31
35
9.13
25.18
2.2
2.2
—
—
—
0
0
50
96
5.45
25.09
5.0
1.5
—
—
—
0
0
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
50
98
5.34
24.53
5.0
1.5
—
—
—
0
0
32
39
8.46
24.50
1.5
5.6
—
34.5
—
0
10
50
99
5.28
24.25
5.0
1.5
—
—
—
0
0
458
3020
2.03
24.08
4.3
2.8
532.7
142.9
ug/l
8.19
439
2752
84
251
3.58
23.94
2.8
3.9
26.3
35.5
mg/l
1.59
72
207
24
20
12.29
23.92
1.3
1.2
—
—
—
0
0
96
317
3.26
23.38
6.8
1.9
—
—
—
0
0
87
285
3.27
21.44
1.8
2.7
9.8
10.5
g/l
0.64
72
243
63
170
3.90
20.79
4.3
1.4
—
—
—
0
0
89
306
3.11
20.22
1.8
2.6
3.6
3.7
g/l
0.36
64
219
89
307
3.10
20.11
1.8
2.6
—
—
—
0
0
89
307
3.10
20.11
1.8
2.6
7.0
7.4
g/l
0.81
64
227
585
4383
1.92
19.37
12.4
5.0
6.8
6.7
mmol/l
0.22
570
4110
85
292
3.11
19.33
2.9
1.7
—
—
—
0
0
319
1970
1.95
19.13
2.5
2.2
3.0
3.1
mg/l
0.26
274
1661
360
2346
1.88
18.11
6.3
3.3
34.2
33.2
u/l
0.13
348
2235
116
487
2.58
18.11
2.9
1.6
—
—
—
0
0
81
285
3.02
17.66
1.9
2.7
3.2
3.1
g/l
0.21
64
223
61
181
3.54
17.53
2.0
1.4
—
—
—
0
0
351
2322
1.83
16.45
3.8
2.6
51.3
57.8
u/l
3.10
330
2142
48
126
3.96
16.45
2.6
2.1
22463.6
2696.0
u/l
0.77
15
42
108
478
2.43
15.00
1.6
1.4
—
—
—
0
0
392
2737
1.75
14.92
4.7
3.4
—
—
—
0
0
32
66
4.99
14.82
2.5
1.6
—
—
—
0
0
15
13
11.71
14.45
1.3
1.0
—
—
—
0
0
58
191
3.17
14.14
1.3
1.3
—
—
—
0
0
51
155
3.42
14.14
1.4
1.6
—
—
—
0
0
49
146
3.49
14.00
3.1
1.3
42.5
968.9
e6/l
0.67
41
119
49
146
3.49
14.00
3.1
1.2
8.3
10.6
e6/l
0.11
39
116
248
1544
1.83
13.73
1.9
1.8
1242.2
1185.5
nmol/l
0.41
220
1153
50
156
3.33
13.31
1.2
1.3
269.9
243.0
miu/ml
0.12
11
72
22
37
6.07
12.63
3.0
2.4
997.2
993.1
u/ml
0.01
22
37
107
512
2.23
12.37
6.2
3.9
0.8
2.0
mmol/l
3.04
86
378
50
164
3.17
12.29
2.6
1.3
497.9
512.8
mg/l
0.09
50
156
67
261
2.69
12.10
1.7
3.0
0.3
1.4
g/l
2.41
61
231
15
5
30.45
11.67
1.7
6.4
—
—
—
0
0
21
37
5.78
11.51
10.2
3.6
227.4
208.1
u/l
0.34
21
37
63
245
2.69
11.42
1.6
2.7
37.5
37.5
g/l
0.04
58
209
672
5648
1.70
11.32
32.3
7.6
83.3
79.6
u/l
1.26
658
5277
23
45
5.22
11.30
2.5
1.6
—
—
—
0
0
23
46
5.10
11.04
2.5
1.6
—
—
—
0
0
15
19
8.01
11.03
2.2
1.6
—
—
—
0
0
108
546
2.11
10.85
6.4
3.9
5.1
5.2
kpa
0.48
102
506
129
705
1.96
10.46
2.8
2.4
0.2
0.2
g/l
0.39
116
657
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
269
2.52
10.41
3.4
2.7
0.3
0.4
u/ml
0.29
37
150
351
2554
1.60
10.39
5.6
3.5
2.3
2.3
mmol/l
6.09
322
2213
24
55
4.45
9.84
2.5
1.5
—
—
—
0
0
23
51
4.60
9.81
3.3
1.6
—
—
—
0
0
46
166
2.86
9.62
1.5
1.4
—
—
—
0
0
46
166
2.86
9.62
1.5
1.4
—
—
—
0
0
32
93
3.53
9.54
1.1
1.0
—
—
—
0
0
9
0
+∞
9.39
5.3
0.0
—
—
—
0
0
17
30
5.75
9.30
1.8
1.3
—
—
—
0
0
222
1486
1.65
9.01
5.0
4.0
86.0
313.2
ng/l
3.30
188
1215
626
7095
0.63
9.00
5.2
5.1
2.5
2.7
mmol/l
4.06
591
6431
268
1880
1.60
8.99
1.9
1.6
19.3
20.4
nmol/l
0.63
250
1583
407
3151
1.52
8.73
2.3
2.0
90.0
94.5
pmol/l
1.14
288
1637
53
221
2.48
8.38
1.5
1.6
—
—
—
0
0
35
119
3.02
8.15
1.2
1.1
—
—
—
0
0
324
2419
1.52
8.09
3.7
3.2
1490.7
1681.4
ng/l
0.27
301
2084
717
7841
0.62
8.07
74.2
23.0
116.4
134.9
g/l
89.90
706
7694
717
7839
0.62
8.01
73.8
22.9
3.9
4.5
e12/l
78.62
700
7594
11
14
7.94
8.00
3.8
1.0
—
—
—
0
0
717
7837
0.62
7.96
73.9
22.9
191.1
244.4
e9/l
35.36
702
7618
42
165
2.62
7.52
2.5
1.4
12.8
8.2
u/l
0.77
37
132
7
0
+∞
7.30
3.0
0.0
8.2
—
ng/l
—
7
0
306
2305
1.49
7.13
3.9
2.1
158.1
256.7
u/l
1.72
295
2158
613
6883
0.67
7.04
4.9
4.5
1.3
1.4
mmol/l
15.70
575
6241
72
370
2.03
6.93
7.2
3.9
24.7
24.2
mmol/l
0.44
65
336
121
746
1.72
6.58
4.9
3.9
2.1
2.2
mmol/l
0.06
97
591
15
33
4.60
6.47
3.5
1.2
16.0
6.2
ug/l
0.84
15
28
6
0
+∞
6.25
1.2
0.0
—
—
—
0
0
41
176
2.39
6.15
1.9
2.1
122.1
128.2
g/l
0.61
30
130
92
535
1.80
6.13
9.8
7.3
24.5
24.4
mmol/l
0.07
87
503
113
700
1.70
6.04
3.8
3.0
220.4
236.7
ng/l
0.22
106
644
557
4787
1.41
6.00
5.8
4.7
163.9
2631.9
e6/l
1.71
15
94
139
922
1.60
5.68
10.1
7.8
4.9
5.1
kpa
1.55
132
879
139
923
1.60
5.65
10.1
7.8
11.6
11.9
kpa
0.47
131
882
628
6932
0.71
5.50
5.2
4.6
4.3
4.6
mmol/l
8.10
598
6329
39
174
2.30
5.39
2.4
1.4
19.3
24.7
iu/l
0.61
32
146
138
925
1.58
5.39
10.7
7.8
1.5
1.3
mmol/l
0.19
103
718
176
1246
1.51
5.37
4.5
3.1
2.5
2.1
e6/l
0.22
100
719
591
6574
0.72
5.25
6.0
6.1
39.8
40.4
mmol/mol
0.80
552
6029
5
0
+∞
5.21
12.4
0.0
—
—
—
0
0
273
2116
1.41
5.17
4.6
3.3
0.4
0.5
e6/l
0.35
215
1622
12
27
4.49
5.04
1.2
1.1
—
—
—
0
0
11
23
4.83
5.02
1.2
1.0
—
—
—
0
0
28
112
2.55
4.91
1.1
1.3
—
—
—
0
0
42
205
2.10
4.70
1.4
1.6
0.2
31.7
iu/ml
—
8
38
26
103
2.57
4.66
1.6
1.3
2168.9
1565.2
e6/l
0.46
20
67
17
53
3.25
4.63
1.4
1.2
—
—
—
0
0
24
93
2.62
4.50
1.6
1.3
83687.4
26420.7
e6/l
0.37
14
49
13
35
3.75
4.37
1.2
1.0
—
—
—
0
0
629
6865
0.74
4.33
6.0
4.8
6.1
6.0
mmol/l
0.86
583
6165
599
5359
1.34
4.18
5.9
4.1
19.4
12.9
mm/h
11.06
564
4901
14
42
3.37
4.05
1.4
1.0
27.1
45.2
mg/l
1.08
14
33
9
14
6.48
3.99
1.0
1.4
—
—
—
0
0
13
38
3.46
3.91
1.3
1.1
—
—
—
0
0
354
2963
1.32
3.88
3.8
3.9
63.1
53.1
ng/l
0.10
277
2171
12
34
3.56
3.77
3.8
1.3
—
—
—
0
0
705
7524
0.73
3.77
37.7
10.7
27.5
26.2
u/l
1.37
685
7221
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
40
3.28
3.63
1.3
1.2
—
—
—
0
0
209
1635
1.36
3.60
3.4
2.7
5.1
5.1
e6/l
0.02
191
1439
172
1304
1.39
3.59
4.2
2.9
1.7
1.1
e6/l
0.77
101
770
13
41
3.20
3.50
1.3
1.0
236.2
238.8
mg/l
0.02
13
35
59
358
1.69
3.47
3.2
3.3
4.5
4.5
pmol/l
0.03
52
310
98
676
1.50
3.38
9.8
7.2
1.4
1.4
mmol/l
0.33
93
644
7
10
7.04
3.37
2.1
4.9
—
—
—
0
0
12
37
3.27
3.35
1.3
1.6
2.8
3.5
ug/l
—
7
29
40
219
1.86
3.32
1.4
1.5
245.4
289.0
ug/g
0.68
24
125
13
46
2.85
2.92
1.6
1.5
3.5
11.8
u/l
—
8
24
6
9
6.70
2.87
1.0
1.2
—
—
—
0
0
6
9
6.70
2.87
1.0
1.3
—
—
—
0
0
49
300
1.67
2.83
1.8
2.0
35.6
39.2
u/l
0.62
42
263
19
84
2.29
2.78
4.4
4.0
—
—
—
0
0
186
2296
0.76
2.78
3.8
4.5
21.5
21.3
%
0.05
89
1139
622
6675
0.79
2.77
41.0
14.6
77.0
78.3
ml/min/173m2
0.64
544
5516
16
66
2.45
2.72
1.3
1.2
10.8
14.1
u/l
0.42
16
60
95
682
1.44
2.71
2.7
2.4
29.3
105.8
u/l
0.55
83
575
620
6642
0.80
2.63
5.4
4.1
1.5
1.3
mmol/l
3.99
587
5992
128
1644
0.74
2.52
2.8
3.1
0.7
0.8
ug/l
0.43
80
1109
17
75
2.29
2.52
1.3
2.2
—
—
—
0
0
201
1648
1.28
2.43
1.6
1.8
74699250.6
7979545.4
pmol/l
0.43
166
1341
29
160
1.84
2.42
2.7
2.5
15.7
15.9
%
0.07
20
80
29
500
0.57
2.41
1.9
1.7
—
—
—
0
0
11
40
2.77
2.38
1.1
1.0
—
—
—
0
0
18
86
2.11
2.24
1.5
1.8
—
—
—
0
0
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
56
378
1.51
2.21
4.4
4.1
46.7
47.3
%
0.06
56
372
36
219
1.67
2.18
1.2
1.2
—
—
—
0
0
36
221
1.65
2.12
1.2
1.2
—
—
—
0
0
332
2919
1.21
2.11
2.8
2.3
75.1
77.8
nmol/l
1.02
309
2555
48
321
1.52
2.00
1.3
1.3
—
—
—
0
0
156
1893
0.79
1.98
2.3
1.6
1.9
1.4
mmol/l
2.38
141
1566
7
21
3.35
1.96
1.0
1.1
—
—
—
0
0
43
282
1.55
1.96
2.8
2.1
151.3
459.7
ug/l
1.17
38
265
67
482
1.42
1.95
14.9
9.2
1.5
1.4
%
0.40
67
477
10
40
2.52
1.84
1.9
1.5
1.8
3.3
u/field
—
5
29
26
153
1.72
1.81
1.2
1.3
—
—
—
0
0
30
185
1.64
1.77
1.5
1.7
—
—
—
0
0
708
7388
0.82
1.75
55.5
18.7
4.0
4.0
mmol/l
0.49
696
7173
8
31
2.59
1.66
1.1
1.3
—
—
—
0
0
77
585
1.35
1.65
4.1
4.1
83.7
90.2
ng/l
0.36
72
514
608
6419
0.84
1.63
5.2
4.6
2.0
2.1
mu/l
0.36
570
5775
89
692
1.32
1.63
2.2
2.6
4.2
6.8
ug/l
1.63
78
605
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
5
15
3.35
1.52
1.4
2.7
—
—
—
0
0
709
7373
0.83
1.52
50.3
18.5
139.2
139.6
mmol/l
4.76
696
7164
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
255
2870
0.85
1.49
4.2
5.2
4.1
3.0
ug/l
0.21
232
2535
5
16
3.14
1.44
1.0
1.0
2.4
4.8
umol/l
—
5
16
6
22
2.74
1.43
1.2
1.2
—
—
—
0
0
6
22
2.74
1.43
1.0
1.2
—
—
—
0
0
15
82
1.84
1.36
1.8
1.3
—
—
—
0
0
603
6331
0.86
1.34
48.7
16.8
35.4
39.6
%
18.71
383
4306
54
404
1.36
1.31
3.3
3.7
24.6
25.3
mmol/l
0.74
54
391
123
1459
0.82
1.27
1.2
1.2
2.3
1.6
u/ml
0.21
31
387
33
229
1.46
1.23
1.5
1.5
1.2
1.2
g/l
0.16
33
217
16
93
1.73
1.21
1.0
1.1
—
—
—
0
0
24
157
1.54
1.18
1.0
1.1
—
—
—
0
0
12
66
1.83
1.09
1.8
2.1
1.0
2.2
u/field
—
5
27
5
21
2.39
1.09
1.0
1.1
—
—
—
0
0
379
3516
1.13
1.08
4.0
3.9
0.0
0.0
estimate
0.00
71
640
15
89
1.70
1.08
1.3
1.2
4.4
6.5
u/ml
—
5
39
111
937
1.21
1.08
3.5
4.6
28.4
31.8
%
2.80
89
611
373
3461
1.13
1.06
4.0
3.9
0.0
0.0
estimate
0.00
77
655
211
2348
0.87
1.03
3.1
3.2
7.7
7.5
mmol/l
0.20
186
1933
14
83
1.70
1.01
1.0
1.1
123.0
116.0
%
0.29
14
77
166
1461
1.17
1.01
3.7
3.1
2.4
2.5
mmol/l
0.09
155
1289
25
172
1.47
1.00
3.0
4.0
38.5
26.7
mg/l
1.11
18
115
51
397
1.30
1.00
16.1
10.2
24.3
24.7
mmol/l
0.33
46
371
38
503
0.74
1.00
1.8
1.9
—
—
—
0
0
212
2352
0.87
0.99
4.0
4.0
13.5
9.8
mg/mmol
0.45
141
1467
9
49
1.84
0.98
1.0
1.3
—
—
—
0
0
48
372
1.31
0.97
2.6
2.5
0.7
0.7
%
0.39
48
361
10
54
1.86
0.97
1.0
1.1
—
—
—
0
0
12
69
1.75
0.96
1.3
1.1
—
—
—
0
0
43
555
0.76
0.95
1.9
2.1
—
—
—
0
0
17
109
1.57
0.94
1.2
1.1
—
—
—
0
0
372
3472
1.12
0.93
5.4
5.3
0.0
0.0
estimate
0.50
76
653
425
4004
1.11
0.89
3.4
2.8
—
—
—
0
0
6
29
2.08
0.89
2.3
4.6
—
—
—
0
0
25
180
1.40
0.82
2.5
3.4
0.8
0.9
nmol/l
0.42
16
146
116
1011
1.17
0.82
1.5
1.5
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
324.8
—
0
16
8
48
1.67
0.79
1.0
1.3
—
—
—
0
0
0
27
0.00
0.77
0.0
1.2
—
8.9
—
0
27
6
34
1.77
0.76
1.8
1.1
231.7
564.3
u/l
—
6
29
0
28
0.00
0.76
0.0
1.6
—
—
—
0
0
105
918
1.16
0.73
11.8
7.7
—
—
—
0
0
209
1919
1.12
0.69
4.3
4.1
0.0
0.0
estimate
0.80
71
635
13
85
1.54
0.69
1.0
1.1
—
—
—
0
0
27
208
1.31
0.62
1.4
1.4
—
—
—
0
0
10
63
1.59
0.62
1.0
1.1
—
—
—
0
0
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
474
4553
1.08
0.59
4.2
3.2
69.9
51.6
u/l
2.49
444
4207
120
1079
1.13
0.58
21.4
27.0
1.2
1.3
inr
0.34
23
148
11
73
1.51
0.56
1.0
1.3
—
—
—
0
0
5
88
0.57
0.56
1.0
1.0
—
2.4
—
0
31
93
830
1.13
0.52
3.5
4.0
15.4
26.3
ug/l
0.32
76
697
26
325
0.79
0.51
1.1
1.0
—
—
—
0
0
22
171
1.29
0.50
1.5
1.3
—
—
—
0
0
10
68
1.48
0.47
1.0
1.1
—
—
—
0
0
18
139
1.30
0.44
2.6
1.9
175.5
226.3
pmol/l
2.11
18
129
5
31
1.62
0.43
3.6
1.7
33.4
54.4
ug/l
—
5
31
5
31
1.62
0.43
1.0
1.1
106.4
163.6
iu/ml
—
5
31
43
369
1.17
0.42
1.7
1.2
508.3
264.7
u/ml
0.42
35
333
5
32
1.57
0.42
1.8
2.0
74.2
47.5
umol/l
—
5
24
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
35
299
1.18
0.37
3.5
3.3
55.3
62.0
u/ml
0.08
35
285
11
147
0.75
0.37
2.3
1.5
—
—
—
0
0
66
592
1.12
0.37
4.0
2.8
65.3
64.0
ml/min/173m2
0.09
34
256
9
71
1.27
0.36
1.0
1.2
—
—
—
0
0
12
90
1.34
0.36
1.4
1.3
0.5
0.6
nmol/l
1.17
12
82
6
46
1.31
0.33
2.3
2.5
—
—
—
0
0
85
788
1.09
0.28
6.3
3.6
—
—
—
0
0
8
63
1.27
0.28
1.0
1.1
72.9
95.7
%
—
8
58
17
140
1.22
0.27
1.1
1.2
—
29.1
—
0
12
281
2715
1.05
0.27
4.1
4.1
—
—
—
0
0
17
141
1.21
0.26
1.2
1.2
—
8.8
—
0
12
114
1075
1.07
0.25
1.2
1.3
1.6
12.0
u/ml
5.38
39
392
118
1120
1.06
0.22
1.2
1.3
25.4
35.8
iu/ml
0.67
41
343
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
8
105
0.76
0.21
1.1
1.1
1.5
1.5
g/l
—
8
94
166
1600
1.05
0.19
4.1
4.3
1.0
1.0
kg/l
1.83
25
233
84
796
1.06
0.18
1.6
1.4
—
—
—
0
0
5
67
0.74
0.17
1.2
1.6
—
—
—
0
0
14
120
1.17
0.16
1.2
1.7
—
—
—
0
0
17
149
1.14
0.15
1.1
1.2
—
—
—
0
0
24
217
1.11
0.14
1.6
2.1
—
—
—
0
0
21
190
1.11
0.13
1.2
1.2
—
18.1
—
0
8
23
252
0.91
0.13
2.0
2.1
—
—
—
0
0
21
191
1.10
0.12
2.9
1.8
44.4
41.3
nmol/l
0.15
21
181
5
46
1.09
0.09
1.8
2.2
13.8
13.1
%
—
5
46
22
204
1.08
0.08
1.8
2.0
—
—
—
0
0
24
225
1.07
0.07
1.8
1.8
—
—
—
0
0
709
7121
0.98
0.07
55.1
15.7
26.6
25.6
mg/l
0.33
656
5721
14
153
0.91
0.07
1.4
1.4
—
—
—
0
0
22
208
1.06
0.05
2.6
2.5
407.3
100.2
ug/min
0.42
12
130
19
179
1.06
0.05
1.2
1.2
—
2.8
—
0
19
18
190
0.95
0.04
1.5
1.6
14074.7
17354.7
e6/l
0.19
11
137
19
181
1.05
0.03
1.2
1.2
—
7.0
—
0
25
41
401
1.02
0.02
1.1
1.2
47.3
117.9
iu/ml
2.05
14
151
527
5283
0.99
0.02
4.2
3.8
14.9
14.9
pmol/l
0.02
491
4715
13
136
0.96
0.00
1.5
1.4
—
—
—
0
0
78
779
1.00
0.00
1.6
1.8
1.6
1.5
%
0.27
66
676
6
59
1.02
0.00
2.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
11.4
—
0
5
6
61
0.98
0.00
1.2
1.0
326.2
285.5
mg/l
—
6
53
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.8
—
75.2
—
0
9
6
61
0.98
0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
0.00
1.4
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MYELOID_LEUKAEMIA – Myeloid leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).